Indegene Inc., FindMeCure, and European Patients’ Academy on Therapeutic Innovation, EUPATI, joined hands to drive advancement and innovation in treatment practices through greater patient engagement in clinical research. By working with FindMeCure’s feasibility data intelligence platform, Indegene aims to further the cause of delivering affordable patient-centric care.
In line with this, Indegene’s donation to the EUPATI patient education scholarship is another step toward enhancing the overall effectiveness of the clinical development process. The company’s contribution aims to boost patient inclusion efforts, aid successful clinical trials, and help bring innovative treatments to the market with EUPATI’s Patient Expert program.
EUPATI is a multi-stakeholder public-private partnership launched in 2012. It provides accessible and innovative education aimed at empowering patients and patient representatives. With patient inclusivity and stakeholder partnership at its core, it enriches the medicines’ R&D process. EUPATI’s commitment to enhancing patient engagement through education is a mission that many leading industry organizations like FindMeCure support.
Indegene is a digital-first life sciences commercialization company that helps biopharmaceutical, emerging biotech, and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. Indegene brings together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide diverse solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives their team and purpose to enable healthcare organizations to be future-ready.
TrialHub is an NLP and AI-powered data intelligence platform dedicated to empowering clinical trial strategists with real-time insights on sites, competition, patients and regulations. Thanks to thousands of validated data sources and the latest Generative AI capabilities we are able to answer any question thus ensuring knowledge across teams and data-driven decision-making towards more successful and patient-friendly clinical trials. Visit trialhub.com to learn more.